Alere Inc q HIV-1/2 Detect Point-of-Care Molecular HIV Assay Receives WHO Prequalification
Alere Inc a global leader in rapid diagnostics, announced that its Alereâ„¢ q HIV-1/2 Detect assay has been awarded World...
Alere Inc a global leader in rapid diagnostics, announced that its Alereâ„¢ q HIV-1/2 Detect assay has been awarded World...
As Adjunctive Therapy for the Treatment of Partial-Onset Seizures and Primary Generalized Tonic-Clonic Seizures in Patients with Epilepsy Eisai...
Norgine B.V. announced that the Ministry of Health in the Netherlands , Ministry van Volksgezondheid, Welzijn en Sport , has...
Takeda Pharmaceutical Company Limited and M2Gen®, a healthcare informatics solutions company, have established a new collaboration to generate broad genomic...
Pfizer Inc. broke ground for its new biologics clinical manufacturing facility in Andover, Massachusetts. Expanding the company’s presence in the...
Cepheid announced that its Xpert® HIV-1 Qual test has been awarded WHO prequalification, making it one of the first molecular...
Shire plc and Kamada Ltd a plasma-derived protein therapeutics company focused on orphan indications, announced that the US FDA has...
Actelion announced the commercial availability of the oral, selective, IP prostacyclin receptor agonist, Uptravi® (selexipag) for the treatment of pulmonary...
Shire plc announced it has agreed to license global rights to all indications for PF-00547659 from Pfizer Inc. ...
Eisai Co Ltd. announced that interim analyses on the latest data for the world's first anti-fractalkine monoclonal antibody E6011, discovered...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.